Sofinnova Partners — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
CinCor PharmaSep 2021
Advancing clinical candidates for cardiovascular, metabolic and kidney diseases.
BiotechCincinnati, US
Marc de Garidel(Executive Officer, Director)
Co-investorsSofinnova Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.